RE: You lot26 May 2026 07:33
There is every chance the proposed commercial partnership could ultimately be positive for shareholders. The market is treating SNT as though it is already dead, despite the company still owning technology with genuine commercial potential in the right hands.
The real concern now is governance, conflicts and related-party arrangements surrounding City Oil / b.grn.
Shareholders funded years of development, placings, dilution and project advancement. Yet the public filings increasingly show value, funding structures and commercial arrangements flowing through Richard Parris-connected entities including Parris Group and Aretiico.
If Sabien ultimately steps away from COF/b.grn while connected private interests continue to benefit from structures built during Sabien’s involvement, serious questions must be answered.
This is not conspiracy theory — the RNS history itself references: related-party funding, royalties, mark-ups, secured factoring arrangements, family-controlled entities, and future contingent fee structures.
Minority shareholders deserve full transparency on:
every pound spent on COF/b.grn,
every related-party payment or accrued benefit,
all intercompany balances,
and exactly who owns what economic rights today.
Allenby Capital, as NOMAD, should also be asked what diligence was undertaken on pricing, fairness and minority-shareholder protection across these related-party transactions.
Shareholders should be demanding answers NOW. I urge all shareholders to do their own research and contact the NOMAD.
-
Something along these lines just to start things off.
I am a shareholder in Sabien Technology Group Plc and request review of whether the company’s public disclosures concerning related-party transactions and associated financing arrangements were sufficiently complete, precise, and internally consistent for minority investors. My concern relates in particular to the 2023 amendment involving additional economic rights acquired from a Richard Parris family-controlled company and possible future fees to b.grn, the 2024 related-party funding terms involving a 20% stock mark-up and a 5% royalty via Aretiico, the 2025 invoice factoring facility at 2.5% per month secured by debenture, and the 2026 strategic review of b.grn, intercompany balances, and COF-related arrangements. I request review of whether the market was given a sufficiently cumulative and comprehensible picture of connected-party benefit, pricing, and dilution risk.
DO NOT LET THIS RAT RIP YOU OFF. IF CITY OIL PROGRESSES SHAREHOLDERS OF SNT SHOULD BENEFIT. NOT JUST THIS RAT AND HIS FAMILY.